Applications of (3S)-2-Carbobenzoxy-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid in Industrial Manufacturing

As the direct manufacturer, we supply (3S)-2-Carbobenzoxy-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid to global industries requiring highly specialized intermediates for advanced synthesis. Below are the key commercial application areas where this material integrates into validated industrial processes.

1. Pharmaceutical Active Ingredient Synthesis

Innovators in pharmaceutical manufacturing select this compound as a chiral building block in the assembly of benzyl-protected isoquinoline derivatives. It commonly features in the multistep synthesis of selective serotonin receptor agonists and antagonists, where precise configuration control is critical for bioactivity. The material enters the process during the early derivatization and condensation stages, followed by deprotection in the final phosphine coupling or amidation steps. Critical process parameters include enantiopurity maintenance and trace impurity control, governed by batch release and regulatory compliance.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia 10.0 (monograph for relevant isoquinoline derivatives)
• U.S. FDA 21 CFR Part 211 (cGMP for finished pharmaceuticals)
• USP general notices & requirements

Typical usage ratio

• Ranges from 0.15 to 0.35 molar equivalents per synthetic sequence, adjusted based on target molecule scale and route design

Downstream process integration

• Feeds into chiral intermediate formation after selective hydrogenation
• Participates in amide coupling or acylation in subsequent stages
• Final deprotection executed under hydrogen transfer or acidolysis conditions
• Purity and solvent residue validated by HPLC and NMR prior to next step

Final product types

• Selective serotonin receptor modulators
• Neurological small molecule actives
• Branded and generic CNS APIs
• Preclinical screening compounds

2. Peptide Drug Development

Peptide contract manufacturers incorporate this protected tetrahydroisoquinoline carboxylic acid in solid-phase and solution-phase peptide assembly, requiring high chiral purity for incorporation of isoquinoline-containing residues. Carbobenzoxy group confers protection during chain elongation, which is later removed under optimized hydrogenolysis. Its use in therapeutic peptide formulation demands strict documentation and in-process QC matching regulatory submissions for clinical development.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• European Pharmacopoeia general chapter 2.2.46 (Peptide APIs)
• FDA Guidance for Industry: Q6A Specifications
• ISO 9001:2015 for documentation traceability

Typical usage ratio

• Incorporated at 1.0 molar equivalent at defined peptide chain position; excess (1.05–1.15 equivalents) applied for coupling enhancements

Downstream process integration

• Coupled to solid support-bound intermediates under standard peptide coupling conditions
• Deblocking follows main peptide chain elongation, completed with catalytic hydrogenation
• Purity monitored by UPLC, MS, and optical rotation
• Yields optimized by controlled pH and coupling agent adjustment

Final product types

• Isoquinoline-modified therapeutic peptides
• Peptide drug candidates for CNS and cardiovascular research
• High-purity clinical research-grade peptides
• GMP-grade peptidomimetic compounds

3. Specialty Chemical Intermediate for Agrochemical Synthesis

Agrochemical manufacturers use this chiral ingredient as a functionalized intermediate in the multistep synthesis of certain plant growth regulators and research agroactives. The carbobenzoxy-protected structure improves chemical stability during harsh reaction conditions, and the material’s consistent chiral contribution is necessary where specific, non-racemic product formation is required for bioactivity and environmental safety.

Industry compliance standards

• EPA 40 CFR Part 158 (Data requirements for pesticide synthesis intermediates)
• ISO 17025 for analytical quality control in agrochemical active substance production
• REACH Regulation (EC) No 1907/2006 compliance for imported intermediates

Typical usage ratio

• Employ 0.1–0.2 molar equivalents relative to the target growth regulator skeleton; refined according to synthetic steps and final activity requirements

Downstream process integration

• Active in construction of heterocyclic ring systems during key cyclization stages
• Deprotection and final functionalization proceed in parallel for intermediates and end products
• Intermediates characterized by LC-MS and chiral HPLC at each step
• Environmental fate and handling procedures followed per final product specifications

Final product types

• Chiral plant growth regulators
• Crop protection candidates for chemical screening libraries
• Lead molecules for agrochemical R&D
• Non-commercial pilot batch agroactive structures

4. Reference Standard Production for Analytical Laboratories

Reference standard companies apply this highly characterized compound as a traceable standard for quantitative NMR and chromatographic calibration when monitoring chiral intermediates in complex synthetic sequences. Laboratories demand strict batch-to-batch consistency and full spectral validation to conform with analytical method validation protocols, essential for certifying material purity through validated reference spectra against known standards.

Industry compliance standards

• ISO 17034:2016 (General Requirements for Reference Material Producers)
• USP General Chapter <1224> (Reference Standards)
• GLP principles as specified in OECD guidelines

Typical usage ratio

• Quantitative use at 0.5–2 mg/mL calibration range, titrated to specific method requirements and instrument detection sensitivity

Downstream process integration

• Dissolved in certified solvents for NMR, HPLC, or GC method calibration
• Employed directly in quality control runs and method development studies
• Reference standards shipped with full CoA including NMR, MS, and elemental analysis data
• Batches archived for long-term inter-laboratory comparison studies

Final product types

• Certified chiral reference standards
• Spectrum-matched QC calibration kits
• Analytical controls for pharmaceutical and chemical industries
• Accredited secondary standards for regulatory submissions